Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
antidilution, antidulution, Aril, assume, Black, bore, buy, companion, Companyalso, condensed, conserve, conventional, conversion, converted, convertible, COSO, Daniel, device, doubt, draft, duration, Enterprise, entitledInternal, expenditure, extinguishment, fall, feature, Gaithersburg, imposition, inability, indefinite, investorsagree, Mendelson, modification, NEA, NOL, noteholder, page, par, Partnership, perception, principle, promissory, quality, rare, repatriation, request, requisite, signature, slower, target, theconvertible, type, unlimited, unpaid, vi, vii, withholding
Removed:
adjust, biopsy, breast, calculation, Canadian, carryback, character, charged, collaboration, contingency, Contingently, default, demand, derive, dosed, downturn, economy, enhance, filing, firm, fragment, fresh, generated, grown, insight, Irinophore, jurisdiction, limit, lung, melanoma, modified, nanoparticle, overview, participate, portion, prostate, resolved, surgery, teleconference, treating, underlying, unfavorably, unsettled, utilization
Filing tables
Filing exhibits
Related press release
CSBR similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-182747) pertaining to the 2010 Equity Incentive plan of Champions Oncology Inc., of our report dated July 28, 2014, with respect to the consolidated financial statements of Champions Oncology, Inc., included in this Annual Report (Form 10-K) for the year ended April 30, 2015.
/s/ Ernst & Young LLP
Baltimore, Maryland
July 29, 2015